Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00051194 |
To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
Condition | Intervention | Phase |
---|---|---|
Glaucoma, Open-Angle Ocular Hypertension |
Drug: Combination IOP Lowering Therapy |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A 6-Week Safety and Efficacy Study of Combination IOP-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension. |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.
Study ID Numbers: | C-02-03 |
Study First Received: | January 3, 2003 |
Last Updated: | March 3, 2006 |
ClinicalTrials.gov Identifier: | NCT00051194 |
Health Authority: | United States: Food and Drug Administration |
Glaucoma POAG OAG OHT |
Glaucoma Eye Diseases Glaucoma, Open-Angle |
Vascular Diseases Hypertension Ocular Hypertension |
Cardiovascular Diseases |